ATE191793T1 - Feststellung der cystic fibrosis oder einer mutation des cftr gens - Google Patents

Feststellung der cystic fibrosis oder einer mutation des cftr gens

Info

Publication number
ATE191793T1
ATE191793T1 AT94902859T AT94902859T ATE191793T1 AT E191793 T1 ATE191793 T1 AT E191793T1 AT 94902859 T AT94902859 T AT 94902859T AT 94902859 T AT94902859 T AT 94902859T AT E191793 T1 ATE191793 T1 AT E191793T1
Authority
AT
Austria
Prior art keywords
pct
hpap
cystic fibrosis
detection
mutation
Prior art date
Application number
AT94902859T
Other languages
English (en)
Inventor
Juan-Lucio Iovanna
Jean-Charles Dagorn
Volker Keim
Jacques Sarles
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE191793T1 publication Critical patent/ATE191793T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4733—Acute pancreatitis-associated protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4712—Cystic fibrosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/38—Pediatrics
    • G01N2800/382—Cystic fibrosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT94902859T 1992-12-24 1993-12-23 Feststellung der cystic fibrosis oder einer mutation des cftr gens ATE191793T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9215730A FR2700011B1 (fr) 1992-12-24 1992-12-24 Détection de la mucoviscidose ou d'une mutation du gêne CFTR au moyen d'un dosage de la PAP.
PCT/FR1993/001299 WO1994015218A1 (fr) 1992-12-24 1993-12-23 Detection de la mucoviscidose ou d'une mutation du gene cftr

Publications (1)

Publication Number Publication Date
ATE191793T1 true ATE191793T1 (de) 2000-04-15

Family

ID=9437118

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94902859T ATE191793T1 (de) 1992-12-24 1993-12-23 Feststellung der cystic fibrosis oder einer mutation des cftr gens

Country Status (9)

Country Link
US (1) US5834214A (de)
EP (1) EP0676052B1 (de)
JP (1) JPH08508093A (de)
AT (1) ATE191793T1 (de)
CA (1) CA2152166C (de)
DE (1) DE69328376T2 (de)
ES (1) ES2148313T3 (de)
FR (1) FR2700011B1 (de)
WO (1) WO1994015218A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69638315D1 (de) 1995-02-22 2011-02-17 Eastern Virginia Med School Ingap-protein und dessen beteiligung an der neogenese pankreatischer inselzellen
US5834590A (en) 1995-02-22 1998-11-10 Eastern Virginia Medical School Of The Medical College Of Hampton Roads Ingap protein involved in pancreatic islet neogenesis
US6458076B1 (en) 2000-02-01 2002-10-01 5 Star Medical Multi-lumen medical device
EP1478929B1 (de) * 2002-02-26 2011-04-06 Hermann Schillers Verfahren zum nachweis von erkrankungen, die auf defekten des proteins cystic fibrosis transmembrane conductance regulator (cftr) beruhen
WO2003094958A1 (en) * 2002-05-09 2003-11-20 Medtronic Minimed, Inc. Immunoprotective methods for beta cell neogenesis
US7033317B2 (en) * 2003-06-05 2006-04-25 Hydrocision, Inc. Disposable endoscope and method of making a disposable endoscope
EP1488798A1 (de) * 2003-06-18 2004-12-22 Institut National De La Sante Et De La Recherche Medicale (Inserm) HIP/PAP polypeptide Zusammensetzung zur Verwendung zur Leberregeneration und zur Vorbeugung von Leberinsuffizienz
US20070224638A1 (en) * 2006-03-27 2007-09-27 Institut Pasteur Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections
WO2014139182A1 (en) 2013-03-15 2014-09-18 Shenzhen Hightide Biopharmaceutical, Ltd. Compositions and methods of using islet neogenesis peptides and analogs thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
US4322274A (en) * 1980-08-28 1982-03-30 Wilson Gregory B Method of diagnosing cystic fibrosis patients and asymptomatic carrier of the cystic fibrosis gene
DE69034115T2 (de) * 1989-08-22 2004-07-15 Hsc Research Development Corp., Toronto Cystic fibrosis gen
CA2037478A1 (en) * 1990-03-05 1991-09-06 Richard Gregory Diagnostic and treatment methods involving the cystic fibrosis transmembrane regulator
FR2661187B1 (fr) * 1990-04-20 1994-08-05 Inst Nat Sante Rech Med Proteine associee a la pancreatite aiguue. moyens pour le diagnostic de la pancreatite aiguue.

Also Published As

Publication number Publication date
EP0676052A1 (de) 1995-10-11
WO1994015218A1 (fr) 1994-07-07
DE69328376D1 (de) 2000-05-18
JPH08508093A (ja) 1996-08-27
FR2700011A1 (fr) 1994-07-01
EP0676052B1 (de) 2000-04-12
CA2152166C (fr) 2004-04-27
FR2700011B1 (fr) 1995-02-24
CA2152166A1 (fr) 1994-07-07
ES2148313T3 (es) 2000-10-16
DE69328376T2 (de) 2000-12-21
US5834214A (en) 1998-11-10

Similar Documents

Publication Publication Date Title
ATE113845T1 (de) Monoklonale antikörper gegen glycolipid-antigene und ihre verwendung.
MX9101117A (es) Anticuerpos modificados y su preparacion
NO331148B1 (no) Anvendelse av et monoklonalt eller polyklonalt antistoff, samt fremgangsmate og kit for in vitro diagnose.
DE69420556D1 (de) Assay für troponin i aus dem herzmuskel
MY108526A (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
ATE182625T1 (de) Rekombinante anti-vla4 antikörpermoleküle
ATE191793T1 (de) Feststellung der cystic fibrosis oder einer mutation des cftr gens
DE69021953D1 (de) Enzymimmuntest für Antigene und dafür verwendbare feste Phase.
DE59209650D1 (de) Monoklonale antikörper gegen c-kit
ATE262537T1 (de) Proliferationsinhibitor von endothellzellen und dessen verwendung
AU3204689A (en) Amyloid protein precursors, genetic probes, antibodies, and methods of use
GR3029483T3 (en) Antibodies against t-cells as therapeutics
DE69504620D1 (de) Monoklonaler Antikörper gegen menschliches Glicentin, Hybridoma zur Herstellung dieses Antikörpers und Testverfahren für menschliches Glicentin unter Verwendung dieses Antikörpers
DE3585049D1 (de) Monoklonale antikoerper.
DE69024871D1 (de) Monoklonaler Antikörper gegen menschliches BCDF und Immuntestverfahren unter dessen Verwendung
AU7913887A (en) Method for the removal of undesired cells from human lymphocyte populations, application of the method in monoclonal antibody production and kit therefor
FI86255B (fi) Monoklonal antiurokinase-antikropp, den innehaollande matris och biokemiska testpackningar, i vilka den anvaendes.
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
DE69531059D1 (de) Antikörperreagens zum aufspüren des aneurysma dissecans der aorta sowie dessen verwendung
AU5853590A (en) Assay for human ventricular myosin lc1 and monoclonal antibody thereto
MY104917A (en) Monoclonal antibodies and methods for diagnosis of phytophora infection
IT8922805A0 (it) Metodo per la determinazione qualitativa e quantitativa di anticorpi diretti contro antigeni batterici attraverso la misurazione fotometrica dell'agglutinazione
EP0205337A3 (de) Chondrozyt-Antigene und monoklonale Antikörper
IT8635859V0 (it) Sordina metallica per contrabbassi, violoncelli e simili
KR900013068A (ko) 체외면역에 의한 항황우독소 단일클론성 항체의 제조방법과 황우독소의 분석방법